South Africa has launched lenacapavir, a new injectable form of pre-exposure prophylaxis, or PrEP. The injection provides six months of protection against HIV infection. It is given twice a year. Health experts say the Lenacapavir PrEP Rollout could be a major step forward for HIV prevention. It offers an alternative to oral PrEP, which requires people to take tablets regularly.…